A Phase 2b Study of KW-6356 in Subjects With Parkinson's Disease on Treatment With Levodopa-containing Preparations
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2019
Price : $35 *
At a glance
- Drugs KW 6356 (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Kyowa Kirin
- 26 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Sep 2018 Status changed from planning to recruiting.
- 04 Sep 2018 New trial record